AVDL
Avadel Pharmaceuticals
AVDL
AVDL
45 hedge funds and large institutions have $55.9M invested in Avadel Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
75% less call options, than puts
Call options by funds: $23K | Put options by funds: $92K
Holders
45
Holding in Top 10
1
Calls
$23K
Puts
$92K
Top Buyers
| 1 | +$583K | |
| 2 | +$434K | |
| 3 | +$417K | |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$360K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$206K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$774K | |
| 3 | -$93K | |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$88.9K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$51K |